Clinical Trial Update: Remifemin Preventing the Climacteric Symptoms in Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating Remifemin for preventing climacteric symptoms in breast cancer patients has completed; specific results are not provided in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Remifemin (Black cohosh extract (Actaea racemosa))

Snippet

Sponsor: Zhejiang Cancer Hospital | Conditions: Effect of Drugs, Safety Issues | Phase 2 | Status: COMPLETED